Cutting-Edge Infectious Disease Diagnostics with CRISPR

Charles Chiu

doi:10.1016/j.chom.2018.05.016

Cutting-Edge Infectious Disease Diagnostics with CRISPR

Cell Host Microbe. 2018 Jun 13;23(6):702-704. doi: 10.1016/j.chom.2018.05.016.

Author

Charles Chiu¹

Affiliation

¹ Department of Laboratory Medicine and Medicine, Division of Infectious Diseases, University of California, San Francisco, San Francisco, CA 94107, USA; UCSF-Abbott Viral Diagnostics and Discovery Center, San Francisco, CA 91407, USA. Electronic address: charles.chiu@ucsf.edu.

Abstract

Three recent Science articles (Chen et al., 2018; Gootenberg et al., 2018; Myhrvold et al., 2018) describe the use of CRISPR-Cas technology to develop point-of-care diagnostics that directly detect viruses from clinical samples. These tests could radically transform approaches to diagnosing infectious diseases at the bedside and in the field.

Publication types

Comment

MeSH terms

CRISPR-Cas Systems*
Clustered Regularly Interspaced Short Palindromic Repeats*
Viruses